Monash IVF Group (ASX:MVF) now expects fiscal 2025 underlying group net profit after tax to be about AU$27.5 million, compared with its previous guidance of between AU$30 million and AU$31 million, according to a Tuesday Australian bourse filing.
The company said its revised guidance reflects its assessment of softer market and operating conditions that worsened in April across all of its geographic markets.
The company added that its new Australian vitro fertilization (IVF) patient resgistration, returning IVF patients for stimulated cycles, and other indicators are currently consistent with the months before it dsiclosed the Brisbane incident, where an embryo was mistakenly implanted into the wrong patient at its Brisbane clinic, resulting in the birth of a child.
The company will disclose its fiscal 2025 results on Aug. 22.